Applied Dna Stock News

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801

U.S. stocks pared losses midway through trading, with the S&P 500 and Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.37% to 32,676.26 while the NASDAQ rose 0.26% to 12,401.57. The S

A step closer to public testing for monkeypox, the update sent trading volume soaring to over 82 million shares, compared to a daily average of 153,000.

Shares of Applied DNA Sciences Inc. APDN, +390.46% skyrocketed 353.7% higher in very volatile trading Tuesday, after the biotechnology company said it initiated validation of a monkeypox virus test. T

Source: Zeedign.com / Shutterstock.com Applied DNA (NASDAQ: APDN ) stock is rocketing higher on Tuesday after the company revealed its starting analytical validation of a monkeypox virus test. The new

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based technologies, today announced that Dr. James A. Hayward, p

Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q2 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Sanjay Hurry - Investor Relations Beth Jantzen - Chief Financial Officer James H

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in cell-free, enzymatic DNA production, today anno

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA to participate in fireside chat at 34th Annual ROTH Investor Conference.

The shares of life sciences company, Applied DNA Sciences <> are rising on Wednesday amid reports that the U.S

Applied DNA Sciences, Inc. (NASDAQ: APDN ) a polymerase chain reaction based DNA manufacturer , closed its previously announced registered direct offering with an institutional investor of 1.5 million shares of common stock at a price of $2.80 per share for gross proceeds of approximately $4.2 million , before deducting the placement agent’s fees and other offering expenses payable by the company. In a concurrent private placement, Applied DNA also issued to the institutional investor in the offering unregistered … Full story available on Benzinga.com

Applied DNA Sciences (APDN) has dropped -12.80% pre-market after pricing its share offering.The company entered into a securities purchase agreement with an institutional investor for

ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022